Seroprevalence of immunoglobulin M (IgM) and IgG antibodies to polysaccharides of Streptococcus pneumoniae in different age groups of Ecuadorian and German children

The age-specific prevalence of serum immunoglobulin M (IgM) antibody to capsular polysaccharides of Streptococcus pneumoniae, as detected by enzyme-linked immunosorbent assay, was studied in 1,301 Ecuadorian children enrolled in a national nutrition and health survey. This prevalence was 6% in infants < 6 months old and increased to 28% in children 6 to 11 months old, 49% in those 12 to 17 months old, and 58% in those 18 to 23 months old. About 80% of the 5-year-old children had this antibody. When tested separately against six different capsular polysaccharides, serum IgM antibody reacted with decreasing frequency with serotype 3, 8, 19, 6, 23, and 1 capsular polysaccharides. We did not observe a broadening of the antibody response with increasing age in the sense that more and more serotypes were recognized. A similar age-related prevalence was found for IgM antibody to the species-specific C-polysaccharide of S. pneumoniae and for IgG antibody to capsular polysaccharides of S. pneumoniae. A smaller German serum collection showed a comparable age-related prevalence of pneumococcus-specific serum IgG and IgM antibodies. The highest incidence of respiratory diseases was observed in 1- and 2-year-old Ecuadorian children. It thus seems that acquisition of serum antibody to S. pneumoniae reflects more the developmental maturation of an immune response than an actual exposure to different pneumococcal serotypes.

[1]  H. Brüssow,et al.  Reactivity of human serum antibody with lipopolysaccharide O 78 antigen from enterotoxigenic Escherichia coli , 1992, Epidemiology and Infection.

[2]  H. Brüssow,et al.  Infectious Gastroenteritis Does Not Act as a Triggering Mechanism for the Synthesis of Serum IgG Antibody to β‐Lactoglobulin , 1991, Journal of pediatric gastroenterology and nutrition.

[3]  M. Alpers,et al.  Pneumococcal vaccine trials in Papua New Guinea: relationships between epidemiology of pneumococcal infection and efficacy of vaccine. , 1991, Reviews of infectious diseases.

[4]  H. Brüssow,et al.  Age-related prevalence of serum antibody to respiratory syncytial virus in Ecuadorian and German children. , 1991, The Journal of infectious diseases.

[5]  J. P. Li,et al.  Virulence, immunity, and vaccine related to Streptococcus pneumoniae. , 1991, Critical reviews in microbiology.

[6]  H. Brüssow,et al.  Age-specific prevalence of antibody to enterotoxigenic Escherichia coli in Ecuadorian and German children. , 1990, The Journal of infectious diseases.

[7]  H. Brüssow,et al.  Prevalence and serotype specificity of rotavirus antibodies in different age groups of Ecuadorian infants. , 1990, The Journal of infectious diseases.

[8]  G. Siber,et al.  Standardization of antibody assays for measuring the response to pneumococcal infection and immunization , 1989, The Pediatric infectious disease journal.

[9]  B. Gray,et al.  Epidemiological studies of Streptococcus pneumoniae in infants: antibody to types 3, 6, 14, and 23 in the first two years of life. , 1988, The Journal of infectious diseases.

[10]  H. Brüssow,et al.  Prevalence of antibodies to rotavirus in different age-groups of infants in Bochum, West Germany. , 1988, The Journal of infectious diseases.

[11]  M. Leinonen,et al.  First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants , 1986, Pediatric infectious disease.

[12]  G. Koki,et al.  Colonisation of Haemophilus influenzae and Streptococcus pneumoniae in the upper respiratory tract of neonates in Papua New Guinea: primary acquisition, duration of carriage, and relationship to carriage in mothers. , 1986, Biology of the neonate.

[13]  A. Krook,et al.  Determination of antibodies to pneumococcal C polysaccharide in patients with community-acquired pneumonia , 1985, Journal of clinical microbiology.

[14]  M. Heidelberger,et al.  Crossreactions of Escherichia coli K and O polysaccharides in antipneumococcal and anti-Salmonella sera , 1985, The Journal of experimental medicine.

[15]  S. Landesman,et al.  A comparison of antibody concentration measured by mouse protection assay and radioimmunoassay in sera from patients at high risk of developing pneumococcal disease. , 1984, Molecular immunology.

[16]  F. Shann,et al.  AETIOLOGY OF PNEUMONIA IN CHILDREN IN GOROKA HOSPITAL, PAPUA NEW GUINEA , 1984, The Lancet.

[17]  R. Douglas,et al.  Antibody response to pneumococcal vaccination in children younger than five years of age. , 1983, The Journal of infectious diseases.

[18]  M. Pichichero,et al.  Epidemiologic studies of Streptococcus pneumoniae in infants: antibody response to nasopharyngeal carriage of types 3, 19, and 23. , 1981, The Journal of infectious diseases.

[19]  R. Douglas,et al.  Immunisation with a polyvalent pneumococcal vaccine. Effect of respiratory mortality in children living in the New Guinea highlands. , 1981, Archives of disease in childhood.

[20]  S. Landesman,et al.  Assessment of the antibody response to pneumococcal vaccine in high-risk populations. , 1981, Reviews of infectious diseases.

[21]  B. Gray,et al.  Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. , 1980, The Journal of infectious diseases.

[22]  D. Gwatkin How many die? A set of demographic estimates of the annual number of infant and child deaths in the world. , 1980, American journal of public health.

[23]  M. Leinonen,et al.  PNEUMOCOCCAL VACCINE AND OTITIS MEDIA , 1980, The Lancet.

[24]  K S Warren,et al.  Selective primary health care: an interim strategy for disease control in developing countries. , 1979, The New England journal of medicine.

[25]  S. Landesman,et al.  Failure of pneumococcal vaccine in children with sickle-cell disease. , 1979, The New England journal of medicine.

[26]  R. Yolken,et al.  Immunological response to infection with human reovirus-like agent: measurement of anti-human reovirus-like agent immunoglobulin G and M levels by the method of enzyme-linked immunosorbent assay , 1978, Infection and immunity.

[27]  A. Ammann,et al.  Immune Response to Acute Otitis Media in Children I. Serotypes Isolated and Serum and Middle Ear Fluid Antibody in Pneumococcal Otitis Media , 1974, Infection and immunity.